Based on studies in human gastric cancer (GC) cells, WNT6 was able to increase resistance to apoptotic cell death induced by chemotherapeutic agents and enhance resistance of GC cells to anthracycline drugs [39]. This evidence concerns the gene WNT6 and gastric cancer.